Asher Bio

San Francisco, United States

Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.

$55.0M raised

Apr 2024

Series C

Top Investors

Y CombinatorWellington ManagementAstraZenecaRA Capital ManagementThird Rock Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Asher Bio raised?

Asher Bio has raised $55.0M in total funding. The most recent round was Series C. The last funding was announced in April 2024.

Who are Asher Bio's investors?

Asher Bio's investors include Y Combinator, Wellington Management, AstraZeneca, RA Capital Management, Third Rock Ventures.

Where is Asher Bio headquartered?

Asher Bio is headquartered in San Francisco, United States.

What does Asher Bio do?

Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.

What stage is Asher Bio at?

Asher Bio is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 16, 2024.

MLA

"Asher Bio — Funding & Investors." VCBacked, April 16, 2024, https://www.vcbacked.co/company/asher-bio. Accessed June 4, 2026.

APA

VCBacked. (2024). Asher Bio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/asher-bio

Wikipedia (cite web)

{{cite web |title=Asher Bio — Funding & Investors |url=https://www.vcbacked.co/company/asher-bio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 16, 2024.